Skip to main content Accessibility help
  • Print publication year: 2005
  • Online publication date: August 2009

6 - Prevention of preterm labour



The delivery of infants at preterm periods of gestation is a major factor contributing to perinatal morbidity and mortality in current obstetric practice in developed countries (ACOG Practice Bulletin 2001). It is associated with short- and long-term sequelae and constitutes a significant problem in terms of mortality, disability and cost to healthcare resources and society. Research efforts to address this problem have increased substantially over the last ten years but have failed in their attempts to improve prediction and prevention of preterm delivery.

Preterm delivery results from a series of disorders implicating maternal and fetal disease, some of which are explained and interrelated while many are of unknown aetiology (Iannucci et al. 1996; Burke and Morrison 2000). Epidemiological risk factors for preterm delivery, which are well established (Olsen et al. 1995; Mercer et al. 1996; Kramer et al. 2001), exert a huge influence on its incidence and outcome. In addition, the overall incidence of preterm delivery appears to be increasing in recent years (Goldenberg and Rouse 1998). The reasons for this increase are complex and have been the source of much debate. It has been speculated that there might have been a recent increased tendency to register live birth at very early gestational ages (i.e. 20–22 weeks) in some countries (Joseph et al. 1998).

Abdalla, H. I., Billett, A., Kan, A. al. (1998) Obstetric outcome in 232 ovum donation pregnancies. Br. J. Obstet. Gynaecol. 105, 332–7.
Abramov, Y., Nadjari, M., Weinstein, al. (2000) Indomethacin for preterm labor: a randomised comparison of vaginal and rectal-oral routes. Obstet. Gynecol. 95, 482–6.
Althuisius, S. M., Dekker, G. A., Hummel, P., Bekedam, D. J. and Geijn, H. P. (2001) Final results of the Cervical Incompetence Prevention Randomized Prevention Trial (CIPRACT): therapeutic cerclage with bed rest versus bed rest alone. Am. J. Obstet. Gynecol. 185, 1106–12.
American College of Obstetricians and Gynecologists (ACOG) Practice Bulletin (2001) Clinical Management Guidelines for Obstetrician-Gynecologists Number 31, October 2001. Assessment of risk factors for preterm birth. Obstet. Gynecol. 98, 709–16.
Ananth, C. V., Misra, D. P., Demissie, K. and Smulian, J. C. (2001) Rates of preterm delivery among Black women and White women in the United States over two decades: an age-period-cohort analysis. Am. J. Epidemiol. 154, 657–65.
Anderson, B. and Nielsen, T. F. (1999) Appendicitis in pregnancy: diagnosis, management and complications. Acta Obstet. Gynecol. Scand. 78, 758–62.
Bernasko, J., Lynch, L., Lapinski, R. and Berkowitz, R. L. (1997) Twin pregnancies conceived by assisted reproductive techniques; maternal and neonatal outcomes. Obstet. Gynecol. 89, 368–72.
Boer, K., Smit, B. J., Huis, A. M. and Hogerzeil, H. V. (1994) Substance use in pregnancy: do we care? Acta Paediatr. Suppl. 404, 65–71.
Burke, C. and Morrison, J. J. (2000) Perinatal factors and preterm delivery in an Irish obstetric population. J. Perinat. Med. 28, 49–53.
Cherukuri, R., Minkoff, H., Feldman, J., Parekh, A. and Glass, L. (1988) A cohort study of alkaloidal cocaine (“crack”) in pregnancy. Obstet. Gynecol. 72, 147–51.
Crowther, C. A. and Moore, V. (2002) Magnesium for preventing preterm birth after threatened preterm labour (Cochrane Review). In The Cochrane Library, Issue 3. Oxford: Update Software
Dennedy, M. C., Friel, A. M., Houlihan, D. D., Smith, T. and Morrison, J. J. (2002) Cannabinoids and the human uterus during pregnancy. J. Soc. Gynecol. Invest. 9, 52A.
Devane, W. A., Hanus, L., Breuer, al. (1992) Isolation and structure of a brain constituent that binds to the cannabinoid receptor. Science 258, 1946–9.
Dinsmoor, M. J., Irons, S. J. and Christmas, J. T. (1994) Premature rupture of the membranes associated with recent cocaine use. Am. J. Obstet. Gynecol. 171, 305–8.
El-Metwally, D., Vohr, B. and Tucker, R. (2000) Survival and neonatal morbidity at the limits of viability in the mid 1990s: 22 to 25 weeks. J. Pediatr. 137, 616–22.
Fan, Y. D., Pastorek, J. G., Miller, J. M. and Mulvey, J. (1987) Acute pyelonephritis in pregnancy. Am. J. Perinatol. 4, 324–6.
Fergusson, D. M., Horwood, J. L. and Northstone, K. ALSPAC Study Team. Avon Longitudinal Study of Pregnancy and Childhood. (2002) Maternal use of cannabis and pregnancy outcome. BJOG 109, 21–7
Fisch, B., Harel, L., Kaplan, al. (1997) Neonatal assessment of babies conceived by in vitro fertilization. J. Perinatol. 17, 473–98.
Fried, P. A., Watkinson, B. and Willan, A. (1984) Marijuana use during pregnancy and decreased length of gestation. Am. J. Obstet. Gynecol. 150, 23–7.
Goldenberg, R. L. and Rouse, D. J. (1998) Prevention of premature birth. N. Engl. J. Med. 339, 313–20.
Goldenberg, R. L., Mayberry, S. K., Copper, R. L., Dubard, M. B. and Hauth, J. C. (1993) Pregnancy outcome following a second-trimester loss. Obstet. Gynecol. 81, 444–6.
Golding, J. (1995) Reproduction and caffeine consumption – a literature review. Early Hum. Dev. 43, 1–14.
Guise, J. M., Mahon, S. M.Aickin, al. (2001) Screening for bacterial vaginosis in pregnancy. Am. J. Prev. Med. 20, S62–72.
Gunter, L. M. (1963) Psychopathology and stress in the life experience of mothers of premature infants. Am. J. Obstet. Gynaecol. 86, 405–20.
Gyetvai, K., Hannah, M. E., Hodnett, E. D. and Ohlsson, A. (1999) Tocolytics for preterm labor: a systematic review. Obstet. Gynecol. 94, 869–77.
Handler, A., Kistin, N., Davis, F. and Ferre, C. (1991) Cocaine use during pregnancy: perinatal outcomes. Am. J. Epidemiol. 133, 818–21.
Hannah, M., Amankwah, K., Barret, al. (1995) The Canadian consensus on the use of tocolytics for preterm labour. J SOGC 17, 1089–115.
Hatch, E. E. and Bracken, M. B. (1986) Effect of marijuana use in pregnancy on fetal growth. Am. J. Epidemiol. 124, 986–93.
Hedegaard, M., Brink Henriksen, T., Sabroe, S. and Secher, N. J. (1993) Psychological distress in pregnancy and preterm delivery. Br. Med. J. 307, 234–9.
Higby, K. and Suiter, C. R. (1999) A risk-benefit assessment of therapies for premature labour. Drug Saf. 21, 35–56.
Hoffman, S. and Hatch, M. C. (1996) Stress, social support and pregnancy outcome: a reassessment based on recent research. Paediatr. Perinatal Epidemiol. 10, 380–405.
Hogue, C. J., Hofmann, S. and Hatch, M. C. (2001) Stress and preterm delivery: a conceptual framework. Paediatr. Perinatal Epidemiol. 15, 30–40.
How, H. Y., Hughes, S. A., Vogel, R. L., Gall, S. A. and Spinnato, J. A (1995) Oral terbutaline in the out patient management of preterm labor. Am. J. Obstet. Gynecol. 173, 1518–22.
Ianucci, T. A., Tomich, P. G. and Gianopoulos, J. G. (1996) Aetiology and outcome of extremely low-birth-weight infants. Am. J. Obstet. Gynecol. 174, 1896–902.
Iizuka, K., Yoshii, A., Samizo, al. (1999) A major role for the Rho-associated coiled coil forming protein kinase in G-protein-mediated Ca2 + sensitisation through inhibition of myosin phosphatase in rabbit trachea. Br. J. Pharmacol. 128, 925–33.
Joseph, K. S., Kramer, M. S., Maecoux, al. (1998) Determinants of preterm birth rates in Canada from 1981 through 1983 and from 1992 through 1994. N. Engl. J. Med. 339, 1434–9.
Kekki, M., Kurki, T., Pelkonen, J., Kurkinen-Raty, M. and Cacciatore, B. J. (2001) Vaginal clindamycin in preventing preterm birth and peripartal infections in asymptomatic women with bacterial vaginosis: a randomised controlled trial. Obstet. Gynecol. 97, 643–8.
Kenyon, S. and Boulvain, M. (2002) Antibiotics for preterm premature rupture of the membranes. In: Cochrane Library, issue 3.
Kenyon, S. L., Taylor, D. J. and Tarnow-Mordi, W.; ORACLE Collaborative Group. (2001a) Broad-spectrum antibiotics for spontaneous preterm labour: the ORACLE II randomised trial. Lancet 357, 989–94.
Kenyon, S. L., Taylor, D. J. and Tarno-Mordi, W.; ORACLE Collaborative Group. (2001b) Broad-spectrum antibiotics for preterm, prelabour rupture of fetal membranes: the ORACLE I randomised trial. Lancet 357, 979–88.
King, J. and Flenady, V. (2002) Antibiotics for preterm labour with intact membranes. In The Cochrane Library, Issue 3. Oxford: Update Software.
Klerman, L. V., Ramsey, S. L., Goldenberg, R. al. (2001) A randomized controlled trial of augmented prenatal care for multiple-risk Medicaid eligible African American women. Am. J. Public Health 91, 105–11.
Koupilova, I., Vagero, D., Leon, D. al. (1998) Social variation in size at birth and preterm delivery in the Czech Republic and Sweden, 1981–1991. Paediatr. Perinatal Epidemiol. 12, 7–24.
Kramer, M. S. (1996) Attributable causes of low birthweight. In Battaglia, F., Falkner, F., and Garza, al., eds. Maternal and Extra-uterine Nutritional Factors: their Influence on Fetal and Infant Growth. Madrid: Ediciones Ergon, pp. 349–57.
Kramer, M. S., Goulet, L., Lydon, al. (2001) socioeconomic disparities in preterm birth: casual pathways and mechanisms. Paediatr. Perinatal Epidemiol. 15, 104–23.
Kurkinen-Raty, M., Vuopala, S., Koskela, al. (2000) A randomised controlled trial of vaginal clindamycin for early pregnancy bacterial vaginosis. BJOG 107, 1427–32.
Kurtzman, J. T., Spinnato, J. A., Goldsmith, L. al. (1999) Human chorionic gonadotrophin exhibits potent inhibition of preterm delivery in a small animal model. Am. J. Obstet. Gynecol. 181, 853–7.
Lees, C. C., Lojacono, A., Thompson, al. (1999) Glyceryl trinitrate and ritodrine in tocolysis: an international multicenter randomized study. GTN Preterm Labour Investigation Group. Obstet. Gynecol. 94, 403–8.
Lobel, M. (1994) Conceptualizations, measurement, and effects of prenatal maternal stress on birth outcomes. J. Behav. Med. 17, 225–72.
Lobel, M., Dunkel-Schetter, C. and Scrimshaw, S. C. M. (1992) Prenatal maternal stress and prematurity: a prospective study of socioeconomically disadvantaged women. Health Psychol. 11, 32–40.
Lumley, J. (1993) The epidemiology of preterm birth. Baillieres Clin. Obstet. Gynaecol. 7, 477–98.
McDonald, H., Brocklehurst, P., Parsons, J. and Vigneswaran, R. (2003) Antibiotics for treating bacterial vaginosis in pregnancy. In The Cochrane Library, Issue 4. Oxford: Update Software.
MacFarlane, A., Cole, S., Johnson, A. and Botting, B. (1988) Epidemiology of birth before 28 weeks of gestation. Br. Med. Bull. 44, 861–91.
McGrady, G. A., Sung, J. F., Rowley, D. L. and Hogue, C. J. (1992) Preterm delivery and low birthweight among first-born infants of black and white college graduates. Am. J. Epidemiol. 136, 266–76.
Macones, G. A., Berlin, M. and Berlin, J. A. (1995) Efficacy of oral beta-agonist maintenance therapy in preterm labour: a meta-analysis. Obstet. Gynecol. 85, 313–17.
Madinger, N. E., Greenspoon, J. S. and Ellrodt, A. G. (1989) Pneumonia during pregnancy: has modern technology improved maternal and fetal outcome? Am. J. Obstet. Gynecol. 161, 657–62.
Matsuda, L. A., Lolait, S. J., Brownstein, M. J., Toung, A. C. and Bonner, T. I. (1990) Structure of a cannabinoid receptor and functional experssion of the cloned cDNA. Nature 346, 561–4.
Mattison, D. R., Damus, K., Fiore, E., Petrini, J. and Alter, C. (2001) Preterm delivery: a public health perspective. Paediatr. Perinatal Epidemiol. 15, 7–16.
Medical Research Council/Royal College of Obstetricians and Gynaecologists (MRC/RCOG) Working Party on Cervical Cerclage. (1993) Final report of the Medical Research Council/Royal College of Obstetricians and Gynaecologists Multicentre Randomized Trial of Cervical Cerclage. BJOG 100, 516–23.
Mercer, B. M., Goldenberg, R. L., Das, al. (1996) The preterm prediction study: A clinical risk assessment system. Am. J. Obstet. Gynecol. 174, 1885–95.
Miller, J. M. and Boudreaux, M. C. (1999) A study of antenatal cocaine use – chaos in action. Am. J. Obstet. Gynecol. 180, 1427–31.
Moran, C. J, Friel, A. M., Smith, T. J., Cairns, M. and Morrison, J. J. (2002) Expression and modulation of Rho kinase in human pregnant myometrium. Mol. Hum. Rep. 8, 196–200.
Morrison, J. J. and Rennie, J. M. (1997) Clinical, scientific and ethical aspects of fetal and neonatal care at extreme preterm periods of gestation. BJOG 104, 1341–50.
Moutquin, J. M., Sherman, D., Cohen, H. (2000) Double blind, randomized, controlled trial of atosiban and ritodrine in the treatment of preterm labor: a multicenter effectiveness and safety study. Am. J. Obstet. Gynecol. 182, 1191–9.
Munro, S., Thomas, K. L. and Abu Shaar, M. (1993) Molecular characterization of a peripheral receptor for cannabinoids. Nature 365, 61–5.
Neerhof, M. G., MacGregor, S. N., Retzky, S. S. and Sullivan, T. P. (1989) Cocaine abuse during pregnancy: peripartum prevalence and perinatal outcome. Am. J. Obstet. Gynecol. 161, 633–8.
Offidani, C., Pomini, F., Caruso, al. (1995) Cocaine during pregnancy: a critical review of the literature. Minerva Ginecol. 47, 381–90.
Olsen, P., Laara, E., Rantakillio, al. (1995) Epidemiology of preterm delivery in two birth cohorts with an interval of 20 years. Am. J. Epidemiol. 142, 1184–93.
Perri, T., Chen, R., Yoeli, al. (2001) Are singleton assisted reproductive technology pregnancies at risk of prematurity. J. Assist. Reprod. Genet. 18, 245–9.
Peruzzi, L., Gianoglio, B., Porcellini, M. G. and Coppo, R. (1999) Neonatal end-stage renal failure associated with maternal ingestion of cyclo-oxygenase-type-1 selective inhibitor nimesulide as tocolytic. Lancet 354, 1615.
Pritchard, C. W. and Teo, P. Y. (1994) Preterm birth, low birthweight and stressfulness of the household role for the pregnant woman. Soc. Sci. Med. 38, 89–96.
Romero, R., Sibai, B. M., Sanchez-Ramos, al. (2000) An oxytocin receptor antagonist (atosiban) in the treatment of preterm labor: a radomized, double blind, placebo-controlled trial with tocolytic rescue. Am. J. Obstet. Gynecol. 182, 1173–83.
Rust, O. A., Atlas, R. O., Jones, K. J., Benham, B. N. and Balducci, J. (2000) A randomised trial of cerclage versus no cerclage among patients with ultrasonographically detected second trimester prefers dilation of the internal os. Am. J. Obstet. Gynecol. 183, 830–5.
Rust, O. A., Atlas, R. O., Reed, J., Gaalen, J. and Balducci, J. (2001) Revisiting the short cervix detected by transvaginal ultrasound in the second trimester: why cerclage therapy may not help. Am. J. Obstet. Gynecol. 185, 1098–105.
Rutter, D. R. and Quine, L. (1990) Inequalities in pregnancy outcome: review of psychosocial and behavioural mediators. Soc. Sci. Med. 30, 553–68.
Sanchez-Ramos, L., Kaunitz, A. M., Gaudier, F. L. and Delke, I. (1999) Efficacy of maintenance therapy after acute tocolysis: A meta-analysis. Am. J. Obstet. Gynecol. 181, 484–90.
Sawdy, R. J. and Bennett, P. R. (1999) Recent advances in the therapeutic management of preterm labour. Curr. Opin. Obstet. Gynecol. 11, 131–9.
Schieve, L. A. and Handler, A. (1996) Preterm delivery and perinatal death among black and white infants in a Chicago-area perinatal registry. Obstet. Gynecol. 88, 356–63.
Shiono, P. H., Klebanoff, M. A., Nugent, R. al. (1995) The impact of cocaine and marijuana use on low birthweight and preterm birth: a multicenter study. Am. J. Obstet. Gynecol. 172, 19–27.
Slattery, M. M. and Morrison, J. J. (2002) Preterm Delivery. Lancet 360, 1485–97.
Soderstrom-Anttila, V., Sajaniemi, N., Tiitinen, A. and Hovatta, O. (1998) Health and development of children born after oocyte donation compared with that of those born after in vitro fertilization, and parents' attitudes regarding secrecy. Hum. Reprod. 13, 2009–15.
Spencer, B., Thomas, H. and Morris, J. (1989) A randomized controlled trial of the provision of a social support service during pregnancy; the South Manchester Family Worker project. BJOG 96, 281–8.
Tambyrajia, R. L. and Mongelli, M. (2000) Sociobiological variables and pregnancy outcome. Int. J. Gynaecol. Obstet. 70, 105–12.
The Canadian Preterm Labor Investigators Group. (1992) Treatment of preterm labor with the beta adrenergic agonist ritodrine. The Canadian Preterm Labor Investigators Group. N. Engl. J. Med. 327, 308–12.
Tsatsaris, V., Papatsonis, D., Goffinet, F., Dekker, G. and Carbonne, B. (2001) Tocolysis with nifedipine or beta-adrenergic agonists: a meta-analysis. Obstet. Gynecol. 97, 840–7.
Uehata, M., Ishizaki, T., Satoh, al. (1997) Calcium sensitisation of smooth muscle mediated by a Rho-associated protein kinase in hypertension. Nature 389, 990–4.
Vermeulen, G. M., Zwet, A. A. and Bruinse, H. W. (2001) Changes in the vaginal flora after two percent clindamycin vaginal cream in women at high risk of spontaneous prefer birth. BJOG 108, 697–700.
Wenstrom, K. D., Weiner, C. P., Merrill, D. and Niebyl, J. (1997) A placebo controlled randomized trial of the terbutaline pump for prevention of preterm delivery. Am. J. Perinatal. 14, 87–91.
Williams, D. R. (1990) Socioeconomic differentials in health: a review and redirection. Soc. Psychol. Quart. 53, 81–99.
Wood, N. S., Marlow, N., Costeloe, K., Gibson, A. T. and Wilkinson, A. R. EPICure study group (2000) Neurological and developmental disability after extremely preterm birth. N. Engl. J. Med. 343, 378–84.
Worldwide Atosiban versus Beta-agonists Study Group. (2001) Effectiveness and safety of the oxytocin antagonist atosiban versus beta-adrenergic agonists in the treatment of preterm labour. The Worldwide Atosiban versus Beta-agonists Study Group. BJOG 108, 133–42.
Wray, S. (1993) Uterine contraction and physiological mechanisms of modulation. Am. J. Physiol. 264, C1–18.
Zhou, W., Sorensen, H. T. and Olsen, J. (1999) Induced abortion and subsequent pregnancy duration. Obstet. Gynecol. 94, 948–53.